CURE is dedicated to conquering childhood cancer through funding targeted research while also supporting patients and their families. They believe that childhood cancer can be cured in our lifetime.
CURE provides two types of research grants: the Translation to Cure (T2C) award and the Early Investigator (EI) award. The grants aim to support innovative childhood cancer research, with the EI award offering up to $220,000 over two years for early-career scientists.